[Clinical value of pelvic lymphadenectomy in surgical treatment of endometrial cancer].

OBJECTIVES

The aim of the study was the clinical analysis of value of pelvic lymphadenectomy in surgical treatment of endometrial carcinoma.

MATERIAL AND

METHODS

The group of 420 women treated for of endometrial cancer in stage IA-IV by FIGO 1988 was analysed. All these women were operated in 2nd Dept. of Obstetrics and Gynecology Medical University of Gdańsk between 1981-2000. The subgroup of patients with pelvic lymphadenectomy was selected. The data were obtained from case histories.

RESULTS

The subgroup of patients on whom pelvic lymphadenectomy was performed was up 32.6% of all treated women (137 women). Neoplastic metastases were found in 27 cases (19.7%). All those patients were in clinical stage II-IV by FIGO 1988, and no earlier stage of endometrial cancer was found in that group. In every case myometrial invasion was more then 1/2 of myometrium. In 59.2% of neoplastic metastases high or medium differential adenocarcinoma were found.

CONCLUSION

Pelvic lymphadenectomy has to be part of surgical treatment of endometrial cancer. Lymph nodes metastases are important prognostic factors. Myometrial invasion plays an important role as a risk factor of lymph nodes metastases.